Mouse motor nerve terminal immunoreactivity to synaptotagmin II during sustained quantal transmitter release
- PMID: 7552284
- DOI: 10.1016/0006-8993(95)00294-z
Mouse motor nerve terminal immunoreactivity to synaptotagmin II during sustained quantal transmitter release
Abstract
An antibody directed against the lumenal NH2-terminus of synaptotagmin II was used to examine the distribution of this vesicular protein either after spontaneous acetylcholine release or after sustained release induced by La3+ or alpha-latrotoxin, in conditions that prevent endocytosis. The detection of the epitope was examined in the presence or absence of Triton X-100. We show that, in resting conditions of transmitter release, permeabilization of nerve terminal membranes is required for obvious detection of synaptotagmin Ii immunoreactivity whereas during sustained rates of quantal release, permeabilization is not necessary. These data indicate that, in the latter conditions, synaptotagmin II is incorporated into the terminal axolemma and its intravesicular domain exposed at the extracellular nerve terminal surface.
Similar articles
-
Synaptotagmin II immunoreactivity in normal and botulinum type-A treated mouse motor nerve terminals.Pflugers Arch. 1996;431(6 Suppl 2):R283-4. doi: 10.1007/BF02346379. Pflugers Arch. 1996. PMID: 8739375
-
Incorporation of synaptotagmin II to the axolemma of botulinum type-A poisoned mouse motor endings during enhanced quantal acetylcholine release.Brain Res. 1998 Jun 29;797(2):357-60. doi: 10.1016/s0006-8993(98)00475-2. Brain Res. 1998. PMID: 9666170
-
Redistribution of synaptophysin and synapsin I during alpha-latrotoxin-induced release of neurotransmitter at the neuromuscular junction.J Cell Biol. 1990 Feb;110(2):449-59. doi: 10.1083/jcb.110.2.449. J Cell Biol. 1990. PMID: 1967610 Free PMC article.
-
The heterogeneity of vesicular acetylcholine storage in cholinergic nerve terminals.Pharmacol Res. 1995 Dec;32(6):345-53. doi: 10.1016/s1043-6618(05)80039-8. Pharmacol Res. 1995. PMID: 8736485 Review.
-
Use of black widow spider venom to study the release of neurotransmitters.Adv Cytopharmacol. 1979;3:87-115. Adv Cytopharmacol. 1979. PMID: 38655 Review. No abstract available.
Cited by
-
Molecular landscape of BoNT/B bound to a membrane-inserted synaptotagmin/ganglioside complex.Cell Mol Life Sci. 2022 Aug 25;79(9):496. doi: 10.1007/s00018-022-04527-4. Cell Mol Life Sci. 2022. PMID: 36006520 Free PMC article.
-
Synaptotagmin II immunoreactivity in normal and botulinum type-A treated mouse motor nerve terminals.Pflugers Arch. 1996;431(6 Suppl 2):R283-4. doi: 10.1007/BF02346379. Pflugers Arch. 1996. PMID: 8739375
-
A molecular basis underlying differences in the toxicity of botulinum serotypes A and E.EMBO Rep. 2004 Nov;5(11):1090-5. doi: 10.1038/sj.embor.7400278. EMBO Rep. 2004. PMID: 15486565 Free PMC article.
-
Moving towards sustainable breeding objectives and cow welfare in dairy production: a South African perspective.Trop Anim Health Prod. 2021 Sep 21;53(5):470. doi: 10.1007/s11250-021-02914-w. Trop Anim Health Prod. 2021. PMID: 34549341 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources